The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection
Abstract
3β‐Hydroxy‐lup‐20(29)‐en‐28‐oic acid (betulinic acid) is a pentacyclic lupane‐type triterpene that is widely distributed throughout the plant kingdom. A variety of biological activities have been ascribed to betulinic acid including anti‐inflammatory and in vitro antimalarial effects. However, betulinic acid is most highly regarded for its anti‐HIV‐1 activity and specific cytotoxicity against a variety of tumor cell lines. Interest in developing even more potent anti‐HIV agents based on betulinic acid has led to the discovery of a host of highly active derivatives exhibiting greater potencies and better therapeutic indices than some current clinical anti‐HIV agents. While its mechanism of action has not been fully determined, it has been shown that some betulinic acid analogs disrupt viral fusion to the cell in a post‐binding step through interaction with the viral glycoprotein gp41 whereas others disrupt assembly and budding of the HIV‐1 virus. With regard to its anticancer properties, betulinic acid was previously reported to exhibit selective cytotoxicity against several melanoma‐derived cell lines. However, more recent work has demonstrated that betulinic acid is cytotoxic against other non‐melanoma (neuroectodermal and malignant brain tumor) human tumor varieties. Betulinic acid appears to function by means of inducing apoptosis in cells irrespective of their p53 status. Because of its selective cytotoxicity against tumor cells and favorable therapeutic index, even at doses up to 500 mg/kg body weight, betulinic acid is a very promising new chemotherapeutic agent for the treatment of HIV infection and cancer. © 2003 Wiley Periodicals, Inc. Med Res Rev, 24, No. 1, 90–114, 2004
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
13C NMR Spectra of pentacyclic triterpenoids—a compilation and some salient features
Mahato, S. B., & Kundu, A. P. (1994) · Phytochemistry · doi:10.1016/s0031-9422(00)89569-2 · Cited by 1,295
Pisha, E., Chai, H., Lee, I.-S., Chagwedera, T. E., Farnsworth, N. R., Cordell, G. A., Beecher, C. W. W., Fong, H. H. S., Kinghorn, A. D., Brown, D. M., et al. (1995) · Nature Medicine · doi:10.1038/nm1095-1046 · Cited by 886
Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells
Zuco, V., Supino, R., Righetti, S. C., Cleris, L., Marchesi, E., Gambacorti-Passerini, C., & Formelli, F. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00718-2 · Cited by 530
Fujioka, T., Kashiwada, Y., Kilkuskie, R. E., Cosentino, L. M., Ballas, L. M., Jiang, J. B., Janzen, W. P., Chen, I.-S., & Lee, K.-H. (1994) · Journal of Natural Products · doi:10.1021/np50104a008 · Cited by 470
Activation of Mitochondria and Release of Mitochondrial Apoptogenic Factors by Betulinic Acid
Fulda, S., Scaffidi, C., Susin, S. A., Krammer, P. H., Kroemer, G., Peter, M. E., & Debatin, K.-M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.33942 · Cited by 369
Fulda, S., Friesen, C., Łoś, M., Scaffidi, C., Mier, W., Benedict, M., Núñez, G., Krammer, P. H., Peter, M. E., & Debatin, K. (1997) · PubMed · Cited by 342
Betulinic Acid and Dihydrobetulinic Acid Derivatives as Potent Anti-HIV Agents
Kashiwada, Y., Hashimoto, F., Cosentino, L. M., Chen, C.-H., Garrett, P. E., & Lee, K.-H. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950922q · Cited by 272
Kashiwada, Y., Wang, H.-K., Nagao, T., Kitanaka, S., Yasuda, I., Fujioka, T., Yamagishi, T., Cosentino, L. M., Kozuka, M., Okabe, H., et al. (1998) · Journal of Natural Products · doi:10.1021/np9800710 · Cited by 269
Betulinic acid: A new cytotoxic agent against malignant brain-tumor cells
Fulda, S., Jeremias, I., Steiner, H. H., Pietsch, T., & Debatin, K.-M. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990730)82:3<435::aid-ijc18>3.0.co;2-1 · Cited by 204
Acetyl-Boswellic Acids Are Novel Catalytic Inhibitors of Human Topoisomerases I and IIα
Syrovets, T., Büchele, B., Gedig, E., Slupsky, J. R., & Simmet, T. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12142-6 · Cited by 182
Cited by
Plants as a source of anti-cancer agents
Cragg, G. M., & Newman, D. J. (2005) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2005.05.011 · Cited by 2,034
Drug discovery from medicinal plants
Balunas, M. J., & Kinghorn, A. D. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.09.012 · Cited by 1,810
Targeting mitochondria for cancer therapy
Fulda, S., Galluzzi, L., & Kroemer, G. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3137 · Cited by 1,629
Pharmacological activities of natural triterpenoids and their therapeutic implications
Dzubak, P., Hajduch, M., Vydra, D., Hustova, A., Kvasnica, M., Biedermann, D., Markova, L., Urban, M., & Sarek, J. (2006) · Natural Product Reports · doi:10.1039/b515312n · Cited by 708
Betulin Is a Potent Anti-Tumor Agent that Is Enhanced by Cholesterol
Mullauer, F. B., Kessler, J. H., & Medema, J. P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005361 · Cited by 688
Pharmacological properties of the ubiquitous natural product betulin
Alakurtti, S., Mäkelä, T., Koskimies, S., & Yli-Kauhaluoma, J. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.04.006 · Cited by 650
Cork: properties, capabilities and applications
Silva, S. P., Sabino, M. A., Fernandes, E. M., Correlo, V. M., Boesel, L. F., & Reis, R. L. (2005) · International Materials Reviews · doi:10.1179/174328005x41168 · Cited by 648
Perspectives for Cancer Prevention With Natural Compounds
Amin, A. R. M. R., Kucuk, O., Khuri, F. R., & Shin, D. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.6235 · Cited by 572
Advances in Pharmacological Activities of Terpenoids
Yang, W., Chen, X., Li, Y., Guo, S., Wang, Z., & Yu, X. (2020) · Natural Product Communications · doi:10.1177/1934578x20903555 · Cited by 496
Pentacyclic Triterpenes of the Lupane, Oleanane and Ursane Group as Tools in Cancer Therapy
Laszczyk, M. (2009) · Planta Medica · doi:10.1055/s-0029-1186102 · Cited by 489
Cancer Prevention With Natural Compounds
Gullett, N. P., Ruhul Amin, A. R. M., Bayraktar, S., Pezzuto, J. M., Shin, D. M., Khuri, F. R., Aggarwal, B. B., Surh, Y.-J., & Kucuk, O. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.06.014 · Cited by 485
Recent developments in anti‐inflammatory natural products
Gautam, R., & Jachak, S. M. (2009) · Medicinal Research Reviews · doi:10.1002/med.20156 · Cited by 475
Betulinic Acid for Cancer Treatment and Prevention
Fulda, S. (2008) · International Journal of Molecular Sciences · doi:10.3390/ijms9061096 · Cited by 343
Birch bark research and development
Krasutsky, P. A. (2006) · Natural Product Reports · doi:10.1039/b606816b · Cited by 337
Betulin and betulinic acid: triterpenoids derivatives with a powerful biological potential
Hordyjewska, A., Ostapiuk, A., Horecka, A., & Kurzepa, J. (2019) · Phytochemistry Reviews · doi:10.1007/s11101-019-09623-1 · Cited by 298
Sheng, H., & Sun, H. (2011) · Natural Product Reports · doi:10.1039/c0np00059k · Cited by 289
Betulin and its derivatives as novel compounds with different pharmacological effects
Amiri, S., Dastghaib, S., Ahmadi, M., Mehrbod, P., Khadem, F., Behrouj, H., Aghanoori, M.-R., Machaj, F., Ghamsari, M., Rosik, J., et al. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.06.008 · Cited by 272
Bauvois, B., & Dauzonne, D. (2006) · Medicinal Research Reviews · doi:10.1002/med.20044 · Cited by 266
Anticancer agents from medicinal plants
Shoeb, M. (2008) · Bangladesh Journal of Pharmacology · doi:10.3329/bjp.v1i2.486 · Cited by 256
D'Adamo, S., Schiano di Visconte, G., Lowe, G., Szaub‐Newton, J., Beacham, T., Landels, A., Allen, M. J., Spicer, A., & Matthijs, M. (2019) · Plant Biotechnology Journal · doi:10.1111/pbi.12948 · Cited by 129
Anti-inflammatory and Cytotoxic Cycloartanes from Guayule ( Parthenium Argentatum )
Flores-Rosete, G., & Martínez-Vázquez, M. (2008) · Natural Product Communications · doi:10.1177/1934578x0800300318 · Cited by 11
Metadata
- Authors
- Cichewicz, R. H., & Kouzi, S. A.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2003-10-22
- Volume
- 24
- Issue
- 1
- Pages
- 90-114
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W2096130774
- Cited by
- 531
- References
- 41
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.